HAMILTON, Bermuda, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. KNSA announced today that it will present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 3:30 p.m. Pacific Time / 6:30 p.m. Eastern Time at the Westin St. Francis Hotel in San Francisco, California. The presentation will be followed by a question and answer session that will begin at 4:00 p.m. Pacific Time / 7:00 p.m. Eastern Time.
A live webcast of Kiniksa's presentation and the question and answer session will be accessible through the Investors & Media section of the company's website at www.kiniksa.com. A replay of the webcast will be available on Kiniksa's website for 14 days following the conference.
About Kiniksa
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa has a pipeline of five product candidates across various stages of development, focused on autoinflammatory and autoimmune conditions. For more information, please visit www.kiniksa.com.
Every Second Counts!™ Kiniksa Investor and Media Contact Mark Ragosa (781) 430-8289 mragosa@kiniksa.com | |
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.